Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RF3F
|
|||
| Former ID |
DIB013720
|
|||
| Drug Name |
MGCD-290
|
|||
| Synonyms |
MG-1; MG-3290; Histone deacetylase inhibitors (cardiovascular diseases), MethylGene; Histone deacetylase inhibitors (diabetes), MethylGene; Histone deacetylase inhibitors (fungal infection), MethylGene; Histone deacetylase inhibitors (inflammation), MethylGene; HDAC inhibitors (non-oncology), MethylGene; Histone deacetylase inhibitors (non-oncology), MethylGene
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
Mirati therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H25N3O2
|
|||
| Canonical SMILES |
C1CC(=O)N(C1)CC(CN2CCN(CC2)C3=CC=CC=C3)O
|
|||
| InChI |
1S/C17H25N3O2/c21-16(14-20-8-4-7-17(20)22)13-18-9-11-19(12-10-18)15-5-2-1-3-6-15/h1-3,5-6,16,21H,4,7-14H2
|
|||
| InChIKey |
AFBKGQPVUQUMRC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 148274-76-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01497223) MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.